GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 13 filers reported holding GAMIDA CELL LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,599,000 | -68.1% | 385,187 | -64.9% | 0.02% | -68.4% |
Q2 2020 | $5,014,000 | +676.2% | 1,097,151 | +412.8% | 0.08% | +484.6% |
Q1 2020 | $646,000 | -10.7% | 213,953 | +27.2% | 0.01% | +30.0% |
Q4 2019 | $723,000 | -7.5% | 168,137 | -7.0% | 0.01% | -9.1% |
Q3 2019 | $782,000 | -30.4% | 180,700 | -18.3% | 0.01% | -26.7% |
Q2 2019 | $1,124,000 | – | 221,229 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
Platform Technology Partners | 45,375 | $291,000 | 0.12% |
PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |